Medicare Enrolled
Dr. Emad Alatassi, M.D.
Critical Care Medicine · Roseville, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alatassi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alatassi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alatassi
Dr. Emad Alatassi is a critical care medicine specialist in Roseville, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Alatassi performed 3,178 Medicare services across 1,441 unique beneficiaries.
Between the years covered by Open Payments, Dr. Alatassi received a total of $8,397 from 36 pharmaceutical and/or device companies across 424 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alatassi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in MI
$8,397 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,178
Medicare services
Top 5% in MI for critical care medicine
1,441
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~159 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,050 | $64 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
360 | $60 | $131 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
283 | $38 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
281 | $92 | $146 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
231 | $31 | $80 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
224 | $38 | $120 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
203 | $106 | $185 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
76 | $85 | $118 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
74 | $266 | $1,085 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
63 | $97 | $127 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
59 | $120 | $238 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
57 | $71 | $176 |
| Remote physiological data monitoring, 30 days Collection and interpretation of physical parameters transmitted by the patient or caregiver over a 30-day period, requiring at least 30 minutes of professional time. |
55 | $43 | $120 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
54 | $281 | $1,134 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
52 | $52 | $258 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
35 | $67 | $373 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
21 | $29 | $110 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,397
Total received (2018-2024)
Avg $1,200/year across 7 years
Top 21% in MI for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
424
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,239 (98.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$157 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,621
2023
$1,747
2022
$1,140
2021
$1,079
2020
$788
2019
$1,025
2018
$997
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$394
GlaxoSmithKline, LLC.
$359
GENZYME CORPORATION
$258
Regeneron Healthcare Solutions, Inc.
$150
Inspire Medical Systems, Inc.
$123
Azurity Pharmaceuticals, Inc.
$107
Mylan Specialty L.P.
$94
Actelion Pharmaceuticals US, Inc.
$60
Resmed Corp
$43
Pulmonx Corporation
$18
Novo Nordisk Inc
$14
Top 3 companies account for 62.4% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$3,022
AstraZeneca Pharmaceuticals LP
$1,409
JAZZ PHARMACEUTICALS INC.
$623
GENZYME CORPORATION
$623
Regeneron Healthcare Solutions, Inc.
$370
Mylan Specialty L.P.
$278
Boehringer Ingelheim Pharmaceuticals, Inc.
$212
Actelion Pharmaceuticals US, Inc.
$211
Sunovion Pharmaceuticals Inc.
$185
Harmony Biosciences LLC
$166
SANOFI-AVENTIS U.S. LLC
$157
Inspire Medical Systems, Inc.
$123
Resmed Corp
$119
Pulmonx Corporation
$111
Azurity Pharmaceuticals, Inc.
$107
Grifols USA, LLC
$104
Inogen, Inc.
$86
Circassia Pharmaceuticals Inc
$73
Takeda Pharmaceuticals U.S.A., Inc.
$53
HARMONY BIOSCIENCES LLC
$43
Baxter Healthcare
$39
Philips Electronics North America Corporation
$34
Mallinckrodt Hospital Products Inc.
$24
Merck Sharp & Dohme LLC
$22
Boston Scientific Corporation
$22
Axsome Therapeutics, Inc.
$22
Teva Pharmaceuticals USA, Inc.
$20
ADVANCED RESPIRATORY, INC
$20
Janssen Pharmaceuticals, Inc
$20
Electromed, Inc.
$17
Gilead Sciences, Inc.
$16
PORTOLA PHARMACEUTICALS, INC.
$15
Novo Nordisk Inc
$14
Insmed, Inc.
$13
E.R. Squibb & Sons, L.L.C.
$12
Aytu BioScience, Inc
$11
Top 3 companies account for 60.2% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSENSE · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AirCurve · AirSense · Arikayce · Astral · BREO · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · DUPIXENT · ELIQUIS · FARXIGA · FASENRA · GLASSIA · HORIZANT · Hillrom - Vest System Model 105 Home Care · IMFINZI · INOGEN · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · InogenOne · LONHALA MAGNAIR · NUCALA · Natesto · OPSUMIT · OPSUMIT MACITENTAN · ProAir Digihaler · Prolastin-C Liquid · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · The Vest System Model 105 Home Care · UPTRAVI · Utibron · Veklury · Wakix · Wellcentive Undiv · XARELTO · XYREM · XYWAV · YUPELRI · ZEPHYR DELIVERY CATHETER
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
80
Per 100K population
9.1
County median income
$76,399
Nearest hospital
Henry Ford Health Warren Hospital
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Alatassi is a clinical cardiology specialist, with above-average Medicare volume (top 5% in MI), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Alatassi experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Alatassi performed 1,050 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alatassi receive payments from pharmaceutical companies?
Yes. Dr. Alatassi received a total of $8,397 from 36 companies across 424 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alatassi's costs compare to other critical care medicines in Roseville?
Dr. Alatassi's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alatassi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Roseville
Browse critical care medicines in Roseville ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in MI
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in MI
Which MI critical care medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
JAZZ PHARMACEUTICALS INC. Payments to Doctors
See all physicians who received payments from JAZZ PHARMACEUTICALS INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology